CVS Pharmacy Enters into $1.2M Settlement with OIG on Double-Billing Claims

CVS Pharmacy, Inc. (CVS) entered into a settlement agreement for $1,216,147.19 with the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services, effective May 28, 2014. The settlement resolves allegations that CVS improperly submitted, or caused to be submitted, duplicate claims to both Medicare Part B and to Medicare Part D plan sponsors or the sponsors' agents. Specifically, CVS allegedly double-billed for immunosuppressant drugs for the same patients on the same date of service. OIG's Office of Audit Services and Office of Counsel to the Inspector General, represented by Senior Counsel Geoffrey Hymans and Associate Counsel Katherine Matos, collaborated to achieve this settlement.

Share